CU6 4.23% $4.98 clarity pharmaceuticals ltd

This Mayo Clinic expert running the Secure trial say the...

  1. 6,688 Posts.
    lightbulb Created with Sketch. 1678

    This Mayo Clinic expert running the Secure trial say the following. (Key excerpts):

    - No red flags- No significant toxicity issues, exciting efficacy, and no supplychain issues from the Secure trial says Mayo Clinic expert.

    - This is probably the best version of a radio pharmaceutical due to the ability to the best concentration in the patient. He is also very complimentary of the Copper pair.

    - If you radiate the cancer cells faster and harder with high doses of Cu67 as this gets more product into the cancer cells faster than the cancer cells can recover, this can lead to cancer cell death, hence preferably over Lutetium or other therapies which don’t deliver high doses to the tumour.

    - MTD : we could keep going beyond 12GBq and we could keep going a lot higher but not see any toxicity. But this may be unnecessary as we are getting more product to the tumour unlike other radio therapies.


 
watchlist Created with Sketch. Add CU6 (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.